Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Nischarin | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | nischarin | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Onchocerca volvulus | Nischarin homolog | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Echinococcus granulosus | nischarin | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0318 | 0.3394 | 0.3394 | |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0614 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | leucyl aminopeptidase | 0.0318 | 0.3394 | 0.3391 |
Brugia malayi | nicalin | 0.0318 | 0.3394 | 0.3391 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0614 | 1 | 1 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Toxoplasma gondii | peptidase, M28 family protein | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Brugia malayi | leucyl aminopeptidase | 0.0318 | 0.3394 | 0.3391 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Leishmania major | hypothetical protein, conserved | 0.0318 | 0.3394 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0614 | 1 | 1 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0614 | 1 | 1 |
Leishmania major | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0614 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Brugia malayi | FXNA | 0.0318 | 0.3394 | 0.3391 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0318 | 0.3394 | 0.3334 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 8509 nM | Inhibition of Sprague-Dawley rat imidazoline I1 receptor | ChEMBL. | 21159515 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.